The global life science tools market is expected to expand sharply over the next decade, according to projections highlighted by SNS Insider. The market was valued at USD 175.96 billion in 2025 and is forecast to reach USD 503.69 billion by 2035, pointing to sustained momentum for companies supplying research and laboratory technologies.
The U.S. is projected to remain a major contributor to that growth. Its market is expected to climb from USD 68.50 billion in 2025 to USD 189.48 billion by 2035. Europe is also set for significant expansion, with the regional market forecast to rise from USD 49.27 billion to USD 133.28 billion over the same period.
The outlook is being supported by rising genomics research and broader adoption of laboratory automation. As research organizations and industry users seek faster workflows and more efficient lab operations, demand for advanced tools and platforms continues to build.
Overall, the forecast suggests a strong long-term market for life science tools as laboratories modernize and biological research becomes more technology-driven. Growth in major regions such as the U.S. and Europe underscores the importance of innovation and infrastructure investment across the sector.
